BIO-TECHNE Corp — Director's Dealing 2016

Aug 26, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2016-08-24

Reporting Person: BAUMGARTNER ROBERT V (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-24	Common Stock	M	3533	$66.59	Acquired	9592	Direct
2016-08-24	Common Stock	S	3533	$107.0981	Disposed	6059	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-24	Stock Option (right to buy)	$66.59	M	3533	Disposed	2017-10-24	Common Stock (3533)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Optin (right to buy)	$87.34	2025-10-28	Common Stock (4260)	4260	Direct
Stock Option (right to buy)	$91.78	2024-10-30	Common Stock (4000)	4000	Direct
Stock Option (right to buy)	$87.39	2023-10-30	Common Stock (4000)	4000	Direct
Stock Option (right to buy)	$66.90	2022-10-24	Common Stock (5000)	5000	Direct
Stock Option (right to buy)	$70.35	2021-10-26	Common Stock (5000)	5000	Direct
Stock Option (right to buy)	$61.46	2020-10-27	Common Stock (5000)	5000	Direct
Stock Option (right to buy)	$63.03	2019-10-28	Common Stock (5000)	5000	Direct
Stock Option (right to buy)	$65.47	2018-10-22	Common Stock (5000)	5000	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.24 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.